UCB

BRU:UCB, BE0003739530
74,620 12:51
-1,500 (-1,97%)

Profiel

UCB is gespecialiseerd in biofarmaceutica. Het verkoopt acht belangrijke producten, voornamelijk in Noord-Amerika en Europa. Cimzia (o.a. de ziekte van Crohn, reumatische artritis en Psoriatische artritis) is goed voor ongeveer 27 procent van de totale omzet (vanaf 2014). Keppra (Epilepsie) 23 procent, Vimpat (Epilepsie) bereikte 16 procent, Neuro (Ziekte van Parkinson en Restless legs Syndrome) 7 procent en Zyrtec (allergie) 6 procent.

Adres

Adres Allée de la Recherche 60
Postcode 1070
Stad Brüssel
Land Belgium
Telefoon +3225599999
Fax
Email Antje.Witte@ucb.com
Website http://www.ucb-group.com

Bestuur

Functie Titel Voornaam Achternaam
CEO Jean-Christophe Tellier
CFO Detlef Thielgen
Chairman (Board of Directors) Evelyn du Monceau
CHRO Jean Luc Fleurial
CMO Iris Löw-Friedrich
COO Charl van Zyl
CSO Dhavalkumar Patel
Member of Board of Directors Jan Berger
Member of Board of Directors Jean-Christophe Tellier
Member of Board of Directors Charles-Antoine Janssen
Member of Board of Directors Albrecht De Graeve
Member of Board of Directors Cédric van Rijckevorsel
Member of Board of Directors Cyril Janssen
Member of Board of Directors Kay Davies
Member of Board of Directors Viviane Monges
Member of Board of Directors Ulf Wiinberg
Member of Board of Directors Alice Dautry
Member of Board of Directors Roch Doliveux
Vice-Chairman (Board of Directors) Pierre Gurdjian

Brussel real time stocks quotedata by Euronext. Other real time EU stocks, by Cboe Europe Ltd.; US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront